UNSW Pharmaceutical Medicine

Why Pharmaceutical Medicine at UNSW?

  • Australasia’s leading postgraduate pharmaceutical medicine program, running for over 20 years
  • Fully delivered online, so you can study anywhere in the world
  • Digital resources and webinars covering the latest innovations in drug development and industry trends
  • Opportunities for internships in industry
  • Developed in partnership with the pharmaceutical industry and government regulators
  • Wide ranging graduate opportunities in early stage research and development, clinical trials, regulatory affairs, pharmacovigilance or medical affairs
  • An alumni network employed by key industry partners such as multinational pharmaceutical companies, biotechnology companies, government regulators and contract organisations

Enquire now (link is external)

Program details

The UNSW programs in Pharmaceutical Medicine are designed to ensure graduates are adequately equipped with the skills needed to competently perform their roles in the pharmaceutical industry. The programs also provide an excellent opportunity for recent graduates in Medical Sciences, and those in a variety of research positions to upgrade skills.

For Australia to play its full role in the development of new drugs, particularly in the early phase of drug development, and to maintain high standards of delivery of drugs to the market, it is essential that Australian pharmaceutical companies have staff adequately trained and skilled to perform in these areas.  

Training in these skills must meet assessable standards which are compatible with international scientific, clinical, legal and regulatory conventions. This is important for Australia to compete in local and international drug development activities and for the career development of those involved.

Those working in Research & Development, Medical, Medical Information and Regulatory Departments in pharmaceutical companies are responsible for the discovery and selection of new drugs for development, their evaluation for efficacy and safety in preclinical and clinical studies, pharmacovigilance (e.g. monitoring and reporting of adverse drug reactions), registration of new drugs and associated regulatory activities, pharmacoeconomic studies, and other activities.

2019 Prospectus

How to apply

Click here to begin the application process.

NB: The Pharmaceutical Medicine program was revised in 2017. Direct enrolments will no longer be accepted for the Graduate Certificate or Graduate Diploma. All entry to the program is through the Master of Pharmaceutical Medicine (program code 9370), with the Graduate Certificate (program code 7370) and Graduate Diploma (program code 5371) providing early exit options to currently enrolled students only.

Please note that the Master of Pharmaceutical Medicine does not qualify graduands to practice as a pharmacist in Australia.


Pharmaceutical Medicine Program 
(02) 9385 2464

November 2018

The Pharmaceutical Medicine team delivered a very successful 1-day Law Masterclass entitled: Therapeutic Good Regulation in Australia: the Challenge of Change

September 2018

Students of Pharmaceutical Medicine program took a trip to the Therapeutic Goods Administration office in Canberra on 13-14 September 2018, where they attended a series of talks and connected with their peers.

June 2018

UNSW Medicine alumna Elizabeth de Somer has been appointed CEO of Medicines Australia.

View the full story here

image - News

November 2017

Dr Chisholm has won the TOPRA Award for Excellence in Regulatory Affairs Education for 2017.

October 2017

Congratulations to Dr Orin Chisholm for her nomination for the award in Excellence in Regulatory Affairs Education from The Organisation for Professionals in Regulatory Affairs (TOPRA).

TOPRA is based in the UK and is an international professional membership organisation for individuals who work in healthcare regulatory affairs. The organisation enables connections and promotes excellence across the healthcare regulatory affairs profession. The winners will be announced at this year’s ceremony which will be held at the Waldorf Hilton in London on 8 November 2017.

September 2017

Very satisfied participants after our 2-day Pharmaceutical Medicine training program for pharmacists from Shandong Province, China.

Students enjoying a tour of the TGA laboratories.

December 2016

Please see the highlights reel from the day below.


Best wishes to you all from the Pharmaceutical Medicine team for the holiday period and the new year!

September 2016

Members of the 2016 Pharmaceutical Medicine cohort recently took a trip to the Therapeutic Goods Administration offices in Canberra, where they met members of staff and connected with their peers.

image - News

May 2015

Dr Chisholm and Jan Cooper attended a very successful ARCS Conference at Randwick Racecourse on 5 - 7 May.  

April 2014

Dr Chisholm & Jan Cooper attended the Pharmaceutical Sciences World Congress in Melbourne from 13 – 16 April

iamge - news

June 2013

Dr Chisholm and Jan Cooper had a very successful time at the ARCS Conference in Sydney on 5 and 6 June.

image - News

April 2013

Dr Chisholm hosted a delegation from the Shaanxi Institute for Food and Drug Control, People’s Republic of China, discussing the regulation of medicines in Australia. Another very successful Weekend School was held at the UNSW campus on 13 and 14 April.

March 2013

Dr Chisholm outlined the Pharmaceutical Medicine and Drug Development programs in the recent edition of “The Source”, a publication by ARCS Australia Ltd, the professional development association for individuals involved in the development of therapeutic products.